The Mayo Alzheimer's Disease Research Center (ADRC) is located in Rochester, MN and Jacksonville, FI and will pursue two primary themes: 1) The recruitment and characterization of subjects on the Alzheimer's disease (AD) degenerative spectrum with a particular focus on early stage disease, mild cognitive impairment (MCI), and 2) the recruitment and characterization of subjects with non-AD dementias including frontotemporal dementia, dementia with Lewy bodies and corticobasal degeneration. These two themes represent a continuation of current activities of the ADRC. The ADRC in its current funding cycle has been active in research on the clinical, neuropsychological, neuroimaging and neuropathological aspects of MCI and will continue these efforts in proposed grant cycle. The Center has also emphasized research in frontotemporal dementia, dementia with Lewy bodies and corticobasal degeneration as well, and this work will expand in the proposed grant period. The ADRC will include 4 Cores: Clinical Core, Biostatistics and Data Management Core, Neuropathology Core and Education and Information Transfer Core. Each of these Cores is led by experts in their respective areas. The Center will also include 3 Projects: 1) Tensor Based Regional Atrophy Rate Measures from Serial Structure MRI and Normal Aging, AD and FTD, 2) The Genetics of Frontotemporal Dementia and Motor Neuron Disease, and 3) Susceptibility Alleles for AD in the IDE Region on Chromosome 10. The Cores and Projects will interact directly. All 3 Projects will draw upon the Clinical, Biostatistics and Data Management and Neuropathology Cores. The Center is designed to conduct research consistent with the themes of the Center and promote AD research within the institution.
| Utianski, Rene L; Whitwell, Jennifer L; Schwarz, Christopher G et al. (2018) Tau-PET imaging with [18F]AV-1451 in primary progressive apraxia of speech. Cortex 99:358-374 |
| Kantarci, Kejal; Tosakulwong, Nirubol; Lesnick, Timothy G et al. (2018) Brain structure and cognition 3 years after the end of an early menopausal hormone therapy trial. Neurology 90:e1404-e1412 |
| Ogaki, Kotaro; Martens, Yuka A; Heckman, Michael G et al. (2018) Multiple system atrophy and apolipoprotein E. Mov Disord 33:647-650 |
| Weintraub, Sandra; Besser, Lilah; Dodge, Hiroko H et al. (2018) Version 3 of the Alzheimer Disease Centers' Neuropsychological Test Battery in the Uniform Data Set (UDS). Alzheimer Dis Assoc Disord 32:10-17 |
| Graff-Radford, Jonathan; Raman, Mekala R; Rabinstein, Alejandro A et al. (2018) Association Between Microinfarcts and Blood Pressure Trajectories. JAMA Neurol 75:212-218 |
| Johnson, Derek R; Hunt, Christopher H; Nathan, Mark A et al. (2018) Pittsburgh compound B (PiB) PET imaging of meningioma and other intracranial tumors. J Neurooncol 136:373-378 |
| Wilmoth, Kristin; LoBue, Christian; Clem, Matthew A et al. (2018) Consistency of traumatic brain injury reporting in older adults with and without cognitive impairment. Clin Neuropsychol 32:524-529 |
| Jones, David T; Knopman, David S; Graff-Radford, Jonathan et al. (2018) In vivo 18F-AV-1451 tau PET signal in MAPT mutation carriers varies by expected tau isoforms. Neurology 90:e947-e954 |
| Alosco, Michael L; Sugarman, Michael A; Besser, Lilah M et al. (2018) A Clinicopathological Investigation of White Matter Hyperintensities and Alzheimer's Disease Neuropathology. J Alzheimers Dis 63:1347-1360 |
| Ting, Simon Kang Seng; Foo, Heidi; Chia, Pei Shi et al. (2018) Dyslexic Characteristics of Chinese-Speaking Semantic Variant of Primary Progressive Aphasia. J Neuropsychiatry Clin Neurosci 30:31-37 |
Showing the most recent 10 out of 1014 publications
